Kristie Bloom

1

Article

0

Comments

Kristie Bloom completed her PhD at AGTRU in 2013 where she developed genome engineering agents to permanently disable HBV. As a post-doctoral researcher at the Uniklinik Freiburg, Germany, she investigated stem cell gene therapy approaches for the treatment of paediatric immunodeficiencies. Since re-joining AGTRU, her research has focused on developing anti-HBV gene therapies and mRNA vaccines for infectious diseases.

Experience

  • –present
    Group Leader: Next-generation Vaccines, Antiviral Gene Therapy Research Unit, University of the Witwatersrand

Contact Kristie for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision